## AFL: AFLAC Incorporated - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 -0.4% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($105.47)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 9
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Aflac Inc - Amended Statement of Ownership (SC 13G/A)**
- Source: ADVFN | 20251209T100738 | Neutral | Relevance: 99%
-  This amended Schedule 13G/A filing for Aflac Incorporated details FMR LLC's and Edward C. Johnson 3d's beneficial ownership of Aflac common stock as of December 31, 2007. It indicates FMR LLC beneficially owns 1.931% of the class, and clarifies that the reporting persons are no longer beneficial owners of more than five percent of the outstanding shares, thus ceasing their reporting obligation under Section 13(d). The document also outlines the ownership structures and voting power within FMR LLC and its subsidiaries.

**2. Aflac EVP beaver sells $377k in stock after option exercise**
- Source: Investing.com | 20251209T152046 | Somewhat-Bullish | Relevance: 99%
- Steven Kent Beaver, EVP and CFO of Aflac Japan (NYSE:AFL), sold 3,452 shares of Aflac common stock for $377,165 on December 5, 2025, after exercising options for the same number of shares. Following the transaction, Beaver directly owns 43,860 shares. This news follows Aflac's strong Q3 2025 earnings and a declared dividend increase for Q1 2026.

**3. Federated Hermes Inc. Purchases 287,362 Shares of Aflac Incorporated $AFL**
- Source: MarketBeat | 20251210T140748 | Bullish | Relevance: 99%
-  Federated Hermes Inc. significantly increased its stake in Aflac Incorporated by 6,692.2% in Q2, acquiring an additional 287,362 shares and holding a total of 291,656 shares valued at $30.76 million. Aflac's board has approved a 100 million share repurchase plan and raised its quarterly dividend, reflecting confidence in the company's value. Institutional ownership of Aflac stands at 67.44%, while some insiders have recently sold shares.

**4. Axa S.A. Decreases Stock Position in Aflac Incorporated $AFL**
- Source: MarketBeat | 20251211T080748 | Neutral | Relevance: 98%
-  Axa S.A. significantly reduced its stake in Aflac Incorporated by 38.9% in the second quarter, selling over 93,000 shares. This move aligns with a trend of insider selling, as company executives sold shares totaling nearly $3 million in the last quarter. Despite the decrease in institutional and insider holdings, Aflac increased its quarterly dividend and analysts maintain a consensus "Hold" rating for the stock.

**5. Aflac EVP beaver sells $377k in stock after option exercise**
- Source: Investing.com Canada | 20251209T160812 | Somewhat-Bullish | Relevance: 98%
- Aflac Executive Vice President and CFO of Aflac Japan, Steven Kent Beaver, sold 3,452 shares of common stock for $377,165 after exercising options to acquire the same number of shares. Following the transaction, Beaver directly owns 43,860 shares of Aflac. This news comes as Aflac reported strong Q3 2025 earnings, exceeding analyst expectations, and announced a dividend increase.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-17 | Morgan Stanley | $118 | $113 | +4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-17 | Morgan Stanley | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.09M) |
| Sells | 8 ($2.54M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.3% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 6 |

**Top Holders:**
- Japan Post Holdings : 10.0% (0.0%)
- Vanguard Group Inc: 9.6% (-0.8%)
- Blackrock Inc.: 7.4% (+0.1%)
- State Street Corpora: 4.6% (+0.1%)
- Wells Fargo & Compan: 2.1% (-24.6%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.93 indicates undervaluation relative to growth. Quality metrics strong (margin 24%). Balance sheet: strong liquidity (48.2x). Insider selling cluster ($2.5M in 90 days), potential headwind. Institutional flow bearish (6 selling vs 3 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $58.2B |
| Beta | 0.66 |
| 52W Range | $96.95 - $115.84 |
| Short Interest | 1.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.93 |
| Forward P/E | 14.8 |
| Current P/E | 14.4 |
| YoY Growth | -2.6% |
| EPS Direction | RISING |

### Technicals

MRS_10 strengthening from -2.3% to -0.4% (+1.9% in 5 days), confirming momentum buildup. Below STRENGTH zone by 3.4pp (needs >3.0% for momentum thesis). MRS_5 turning positive (0.5%) - potential reversal signal. Long-term uptrend intact (above SMA200 at 1.02x) but short-term weakness (below SMA20). RSI neutral at 46.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.41% (CS: 34) | Neutral |
| RSI_14 | 45.8 | Neutral |
| MACD Histogram | -0.33 | Bearish |
| vs SMA20 | 0.987x | Below |
| vs SMA50 | 0.989x | Below |
| vs SMA200 | 1.020x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $108.85
- **Stop Loss:** $105.47 (3.1% risk)
- **Target:** $112.23 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 408
- **Position Value:** $44,410.80
- **Portfolio %:** 44.41%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-04 (Est: $1.71)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.78 | $2.49 | +40.2% |
| 2025Q2 | $1.71 | $1.78 | +4.3% |
| 2025Q1 | $1.67 | $1.66 | -0.8% |
| 2024Q4 | $1.62 | $1.56 | -3.5% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_10*